Participant flow

Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS · Source last updated 2016-10-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Ex vivo selective depletion of alloreactive donor T lymphocytes utilizing "RFT5-SMPT-dgA", a specific anti-interleukin-2 receptor immunotoxin in matched, nonmyeloablative, peripheral blood stem cell transplantation for hematologic malignancies in older adults

   id

   FG000

   title

   "RFT5-SMPT-dgA", an Anti-interleukin, Used in Transplants

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         2

      type

      Withdrawal by Subject

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Technical failure of manipulation

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         25

      type

      STARTED

   2. achievements

      1. comment

         One patient who received a transplant did not meet eligibility and was a special exemption.

         group Id

         FG000

         num Subjects

         22

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         3

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

2 enrolled patients were not transplanted: one, because of donor refusal and the other because she was transplanted elsewhere

recruitment Details

Recruitment dates: 9/21/01 to 11/14/05 Location: Quaternary referral institute

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice